Novo Nordisk A/S (NEO:NVON)
5.48
-0.18 (-3.18%)
Sep 9, 2025, 10:13 AM EDT
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of CAD 335.18 billion as of September 9, 2025. Its market cap has decreased by -58.55% in one year.
Market Cap
335.18B
Enterprise Value
352.64B
Revenue
66.98B
Ranking
n/a
PE Ratio
14.05
Stock Price
5.48
Market Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 9.70B to 335.18B, an increase of 3,354.94%. That is a compound annual growth rate of 13.20%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 8, 2025 | 335.18B | -39.63% |
Dec 30, 2024 | 555.20B | -8.91% |
Dec 29, 2023 | 609.54B | 47.94% |
Dec 30, 2022 | 412.02B | 26.32% |
Dec 30, 2021 | 326.16B | 56.94% |
Dec 30, 2020 | 207.82B | 16.57% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Royal Bank of Canada | 281.31B |
The Toronto-Dominion Bank | 176.12B |
Enbridge | 145.81B |
Brookfield | 140.90B |
Brookfield Asset Management | 130.11B |
Bank of Montreal | 125.15B |
The Bank of Nova Scotia | 109.09B |
Thomson Reuters | 109.03B |